Corona Remedies consolidated net profit rises 30.11% in the June 2026 quarter

Sales rise 21.90% to Rs 422.43 crore

Net profit of Corona Remedies rose 30.11% to Rs 60.11 crore in the quarter ended June 2026 as against Rs 46.20 crore during the previous quarter ended June 2025. Sales rose 21.90% to Rs 422.43 crore in the quarter ended June 2026 as against Rs 346.54 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	422.43	346.54	22
OPM %	22.05	20.08	-
PBDT	93.60	69.61	34
PBT	80.36	60.69	32
NP	60.11	46.20	30

Powered by Capital Market - Live News